Forward Looking Statements





When used in this Form 10-K and in future filings by the Company with the
Commission, The words or phrases such as "anticipate," "believe," "could,"
"would," "should," "estimate," "expect," "intend," "may," "plan," "predict,"
"project," "will" or similar expressions are intended to identify
"forward-looking statements" within the meaning of the Private Securities
Litigation Reform Act of 1995. Readers are cautioned not to place undue reliance
on any such forward looking statements, each of which speak only as of the date
made. Such statements are subject to certain risks and uncertainties that could
cause actual results to differ materially from historical earnings and those
presently anticipated or projected. The Company has no obligation to publicly
release the result of any revisions which may be made to any forward-looking
statements to reflect anticipated or unanticipated events or circumstances
occurring after the date of such statements.

   12


   Table of Contents






These forward-looking statements involve known and unknown risks, uncertainties
and other factors that may cause actual results to be materially different.
These factors include, but are not limited to, changes that may occur to general
economic and business conditions; changes in current pricing levels that we can
charge for our services or which we pay to our suppliers and business partners;
changes in political, social and economic conditions in the jurisdictions in
which we operate; changes to regulations that pertain to our operations; changes
in technology that render our technology relatively inferior, obsolete or more
expensive compared to others; foreign currency fluctuations; changes in the
business prospects of our business partners and customers; increased
competition, including from our business partners; delays in the delivery of
broadband capacity to the homes and offices of persons who use our services;
general disruptions to Internet service; and the loss of customer faith in the
Internet as a means of commerce.



The following discussion should be read in conjunction with the financial statements and related notes which are included in this report under Item 8.

We do not undertake to update our forward-looking statements or risk factors to reflect future events or circumstances.





Overview



General



On May 16, 2011, we transferred, through a spin-off to our then wholly owned
subsidiary, Worlds Online Inc. (currently named MariMed Inc.), the majority of
our operations and related operational assets. We retained our patent portfolio
which we intend to continue to increase and to more aggressively enforce against
alleged infringers. We also entered into a License Agreement with MariMed Inc.
to sublicense patented technologies, which agreement has since expired.



At present, the Company's anticipated sources of revenue will be from any revenue that may be generated from enforcing its patents.





Revenues



We generated no revenue during the year because we transferred the operations of
the Company to MariMed Inc. and our other anticipated revenue generation streams
did not produce any income during the quarter.



Expenses


We classify our expenses into two broad groups:





•  cost of revenues; and




•  selling, general and administration.



Liquidity and Capital Resources





We have had to limit our operations since mid- 2001 due to a lack of
liquidity. However, we were able to issue equity and convertible debt in the
last few years and raise small amounts of capital from time to time that, prior
to the spinoff, was used to enable us to begin upgrading our technology, develop
new products and actively solicit additional business, and more recently to
protect, increase and enforce our patent portfolio.

   13


   Table of Contents




Although we have been able to generate funds through our sale of shares of
MariMed Inc., we continue to pursue additional sources of capital though we have
no current arrangements with respect to, or sources of, additional financing at
this time and there can be no assurance that any such financing will become
available. If we cannot raise additional capital, form an alliance of some
nature with another entity, raise more funds through the sale of shares of
MariMed Inc., or start to generate sufficient revenues, we may be unable to
purchase additional patents or otherwise expand operations through acquisition
or otherwise.



RESULTS OF OPERATIONS


Year ended December 31, 2021 compared to year ended December 31, 2020





Revenue was $0 for the years ended December 31, 2021 and 2020. All the
operations were transferred over to MariMed Inc. in the spin off. The Company's
sources of revenue are anticipated to be from enforcing our patents in
litigation or otherwise.  We still need to raise a sufficient amount of capital
to provide the resources required that would enable us to expand our business.



Selling general and administrative (S, G & A) expenses increased by $508,526
from $1,031,472 to $1,539,998 for the year ended December 31, 2021.  The
increase is due to an increase in legal costs related to the patent infringement
litigation cases.



Salaries and related expenses increased by $7,670 to $215,332 from $207,662 for
the year ended December 31, 2021. Salaries and related are in line with last
year and are based on the terms of the CEO's employment agreement.



For the year ended December 31, 2021, the Company recorded an option expense of
$109,874, representing the amortization of the value of the options issued in
2020 that have not yet vested.



For the year ended December 31, 2020, the Company recorded an option expense of
$267,647, representing the amortization of the value of the options issued in
2020 and 2018 that have not yet vested.



For the year ended December 31, 2021, the Company had interest expense of
$76,063. For the year ended December 31, 2020, the Company had interest expense
of $76,091. The Company is accruing interest on old notes payable that are well
past the statute of limitations and for which the Company never expects to

pay
back.


For the year ended December 31, 2021, the Company had interest income of $14,194.

For the year ended December 31, 2020, the Company had interest income of $14,233.

For the year ended December 31, 2021, the Company recorded a loss on issuance of shares for services of $8,685.

For the year ended December 31, 2021, the Company had a gain on sale of marketable securities of $1,006,588. The Company did not sell any marketable securities for the year ended December 31, 2020.

For the year ended December 31, 2021, the Company had income from the settlement of litigation in the amount of $315,000.

As a result of the foregoing, we had a net loss of $614,170 for the year ended December 31, 2021 compared to a net loss of $1,568,639 for the year ended December 31, 2020.



   14


   Table of Contents



Liquidity and Capital Resources

At December 31, 2021, our cash and cash equivalents were $44,421. We did not raise any additional cash during the year ended December 31, 2021.

At December 31, 2020, our cash and cash equivalents were $474,587.

No capital expenditures were made in 2021 or 2020.

Our primary cash requirements have been used to fund the cost of operations, lawsuits, and patent enforcement.

Recent Accounting Pronouncements

Recently issued accounting standards

The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and does not believe the future adoption of any such pronouncements may be expected to cause a material impact on its financial condition or the results of its operations.



   15


   Table of Contents




ITEM 8. FINANCIAL STATEMENTS.

                                      CONTENTS

  REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM   (Auditor firm ID 2738)                                                   17

  BALANCE SHEETS                                                                19

  STATEMENTS OF OPERATIONS                                                      20

  STATEMENT OF STOCKHOLDERS' DEFICIT                                            21

  STATEMENTS OF CASH FLOWS                                                      22

  NOTES TO FINANCIAL STATEMENTS                                                 23




   16


   Table of Contents




                               [[Image Removed]]



            REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Board of Directors and
Stockholders of Worlds, Inc.

Opinion on the Financial Statements



We have audited the accompanying balance sheets of Worlds, Inc. (the Company) as
of December 31, 2021 and 2020, and the related statements of operations,
stockholders' deficit, and cash flows for each of the years in the two-year
period ended December 31, 2021, and the related notes (collectively referred to
as the financial statements). In our opinion, the financial statements present
fairly, in all material respects, the financial position of the Company as of
December 31, 2021 and 2020, and the results of its operations and its cash flows
for each of the years in the two-year period ended December 31, 2021, in
conformity with accounting principles generally accepted in the United States of
America.

Going Concern

The accompanying financial statements have been prepared assuming that the
Company will continue as a going concern. As discussed in Note 1 to the
financial statements, the Company has suffered net losses from operations and
has a net capital deficiency, which raises substantial doubt about its ability
to continue as a going concern. Management's plans regarding those matters are
discussed in Note 1. The financial statements do not include any adjustments
that might result from the outcome of this uncertainty.

Basis for Opinion



These financial statements are the responsibility of the Company's management.
Our responsibility is to express an opinion on the Company's financial
statements based on our audits. We are a public accounting firm registered with
the Public Company Accounting Oversight Board (United States) (PCAOB) and are
required to be independent with respect to the Company in accordance with the
U.S. federal securities laws and the applicable rules and regulations of the
Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those
standards require that we plan and perform the audit to obtain reasonable
assurance about whether the financial statements are free of material
misstatement, whether due to error or fraud. The Company is not required to
have, nor were we engaged to perform, an audit of its internal control over
financial reporting. As part of our audits, we are required to obtain an
understanding of internal control over financial reporting, but not for the
purpose of expressing an opinion on the effectiveness of the Company's internal
control over financial reporting. Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risks of material
misstatement of the financial statements, whether due to error or fraud, and
performing procedures that respond to those risks. Such procedures included
examining, on a test basis, evidence regarding the amounts and disclosures in
the financial statements. Our audits also included evaluating the accounting
principles used and significant estimates made by management, as well as
evaluating the overall presentation of the financial statements. We believe that
our audits provide a reasonable basis for our opinion.

Critical Audit Matters


The critical audit matters communicated below are matters arising from the
current period audit of the financial statements that were communicated or
required to be communicated to the audit committee and that: (1) relate to
accounts or disclosures that are material to the financial statements and (2)
involved our especially challenging, subjective, or complex judgments. The
communication of critical audit matters does not alter in any way our opinion on
the financial statements, taken as a whole, and we are not, by communicating the
critical audit matters below, providing separate opinions on the critical audit
matters or on the accounts or disclosures to which they relate.

  17


  Contents

Note Receivable Related Party


The Company loaned a material amount of money to a related party that they have
asserted was within the normal course of business for a future business
transaction. The note is convertible into common stock of another related party
company. Management's position on the legality of this payment and the
realizability of the asset are inherently riskier and more complex than they
would be had this been an arm's length transaction. We evaluated the evidence
provided by management for the business purpose of this loan and the current
valuation of the stock that this asset is convertible into. There is a large
reliance on managements representations about this transaction. Notes receivable
related party is discussed in Notes 7 & 11 to the financial statements.

Going Concern


As discussed in Note 1 to the financial statements, the Company had a going
concern due to a working capital deficiency and stockholders' deficiency.
Auditing management's evaluation of a going concern can be a significant
judgment given the fact that the Company uses management estimates on future
revenues and expenses, which are not able to be substantiated. To evaluate the
appropriateness of the going concern, we examined and evaluated the financial
information that was the initial cause along with management's plans to mitigate
the going concern and management's disclosure on going concern.



/s/ M&K CPAS, PLLC

We have served as the Company's auditor since 2018.

Houston, TX

March 30, 2022






  18


  Contents




Worlds Inc.
Balance Sheets
December 31, 2021 and 2020
                                                          Audited                     Audited
                                                     December 31, 2021           December 31, 2020

ASSETS:
Current Assets

Cash and cash equivalents                           $           44,421     

    $          474,587
Other Assets                                                     8,222                          -
Total Current Assets                                            52,643                     474,587

Convertible Note Receivable - related party                    200,000                     200,000
Accrued interest receivable - related party                     31,461                      17,267
Total assets                                        $          284,104     

$ 691,854



LIABILITIES AND STOCKHOLDERS' DEFICIT:
Current Liabilities
Accounts payable                                    $          975,255          $          981,898
Accrued expenses                                             1,546,480                   1,606,565
Notes payable exceeding statute of
limitations                                                    773,279                     773,279
Total Current Liabilities                                    3,295,014                   3,361,742

Total Liabilities                                            3,295,014                   3,361,742

Stockholders' Deficit
Common stock (Par value $0.001 authorized
250,000,000 shares, issued and outstanding
57,112,506 at December 31, 2021 and
56,814,833 at December 31, 2020                                 57,113     

                56,815
Additional paid in capital                                  41,513,730                  41,240,880
Common stock-warrants                                        1,206,913                   1,206,913
Accumulated deficit                                        (45,788,666 )               (45,174,496 )
Total stockholders' deficit                                 (3,010,910 )                (2,669,888 )

Total Liabilities and stockholders' deficit $ 284,104


    $          691,854

             The accompanying notes are an integral part of these financial statements








  19


  Contents




Worlds Inc.
Statements of Operations
For the Year Ended December 31, 2021 and
2020

                                                                  Audited
                                                                December 31,
                                                         2021                  2020
Revenues
Revenue                                             $         -           $         -

Total Revenue                                                 -                     -

Cost and Expenses

Cost of Revenue                                               -                     -

Gross Profit/(Loss)                                           -                     -

Option expense                                           109,874               267,647
Selling, General & Admin.                              1,539,998             1,031,472
Salaries and related                                     215,332               207,662

Operating loss                                        (1,865,204 )          (1,506,781 )

Other Income (Expense)

Loss on issuance of shares for services                   (8,685 )         

-


Gain on sale of marketable securities                  1,006,588           

        -
Settlement of litigation                                 315,000                    -
Interest income                                           14,194                14,233
Interest expense                                         (76,063 )             (76,091 )
Net Loss                                            $   (614,170 )        $ (1,568,639 )
Weighted Average Loss per share - basic             $      (0.01 )        $      (0.03 )
Weighted Average Loss per share - fully
diluted                                             $      (0.01 )        $      (0.03 )
Weighted Average Common Shares Outstanding
(reflecting the reverse stock split) - basic          57,072,544           

56,814,833


Weighted Average Common Shares Outstanding
(reflecting the reverse stock split) - fully
diluted                                               57,072,544           

56,814,833

The accompanying notes are an integral part of these financial statements




  20


  Contents






Worlds Inc.
Statement of Stockholders' Deficit
For the Years Ended December 31, 2020 and 2021
                                                                                                                               Total
                                                                         Additional        Common         Accumulated      stockholders'
                                      Common stock     Common stock       Paid-in           Stock           Deficit           equity
                                         Shares           Amount          capital         Warrants                           (deficit)

 Balances, December 31, 2019           56,814,833           56,815       40,897,142       1,206,913       (43,605,857 )      (1,444,987 )
 Stock options expense                         -                -           267,647              -                 -            267,647
 Imputed Interest                              -                -            76,091              -                 -             76,091
Common stock issued for settlement
of accounts payable - related
party
Gain on forgiveness of accounts
payable - related party
 Net Loss                                      -                -                -               -         (1,568,639 )      (1,568,639 )

 Balances, December 31, 2020           56,814,833           56,815       41,240,880       1,206,913       (45,174,496 )      (2,669,888 )

Common stock issued for settlement
of accounts payable - related
party                                     297,673              298           70,512              -                 -             70,810
Gain on forgiveness of accounts
payable - related party                        -                -            16,401              -                 -             16,401
 Stock options expense                         -                -           109,874              -                 -            109,874
 Imputed Interest                              -                -            76,063              -                 -             76,063
 Net Loss                                      -                -                -               -           (614,170 )        (614,170 )

 Balances, December 31, 2021           57,112,506           57,113       41,513,730       1,206,913       (45,788,666 )      (3,010,910 )

                                The accompanying notes are an integral part of these financial statements






  21


  Contents






Worlds Inc.
Statements of Cash Flows
Year Ended December 31, 2021 and 2020
                                                       Audited              

Audited

12/31/21

12/31/20


Cash flows from operating activities:
Net loss                                            $   (614,170 )        $ (1,568,639 )
Adjustments to reconcile net loss to net
cash (used in) operating activities
Fair value of stock options issued                       109,874           

267,647


Imputed interest                                          76,063           

76,091


Loss on shares issued for settlement of
accounts payable - related party                           8,685           

-


Realized gain on sale of marketable
securities                                            (1,006,588 )         

-


Other assets                                              (8,222 )         

-


Accounts payable and accrued expenses                     11,798           

142,878


Net cash (used in) operating activities:              (1,422,560 )         

(1,082,023 )



Cash flows from investing activities:
Accrued interest receivable - related party              (14,194 )             (14,234 )
Cash received from sale of marketable
securities                                             1,006,588           

-


Cash provided from investing activities:                 992,394           

(14,234 )



Net increase/(decrease) in cash and cash
equivalents                                             (430,166 )         

(1,096,257 )



Cash and cash equivalents, including
restricted, beginning of year                            474,587           

1,570,844



Cash and cash equivalents, including
restricted, end of period                           $     44,421          $

474,587



Non-cash financing activities
Shares issued for settlement of accounts
payable - related party                                   62,125           

-


Gain on forgiveness of account payable -
related party                                             14,401           

-



Supplemental disclosure of cash flow
information:
Cash paid during the year for:
Interest                                            $         -           $         -
Income taxes                                        $         -           $         -

       The accompanying notes are an integral part of these financial statements






  22


  Contents






                                  Worlds, Inc.

                       Notes to the Financial Statements





NOTE 1 - GOING CONCERN



As reflected in the accompanying financial statements, the Company has a working
capital deficiency of $3,242,371 and a stockholder's deficiency of $3,010,910
and used $1,422,560 of cash in operations for the year ended December 31, 2021.
This raises substantial doubt about its ability to continue as a going concern.
The ability of the Company to continue as a going concern is dependent on the
Company's ability to raise additional capital and implement its business plan.
The financial statements do not include any adjustments that might be necessary
if the Company is unable to continue as a going concern.



Management believes that the actions presently being taken to obtain additional funding and implement its strategic plans provide the opportunity for the Company to continue as a going concern.

NOTE 2 - DESCRIPTION OF BUSINESS AND SUMMARY OF ACCOUNTING POLICIES





Description of Business



On May 16, 2011, the Company transferred, through a spin-off to its then wholly
owned subsidiary, Worlds Online Inc. (currently called MariMed Inc.), the
majority of its operations and related operational assets. The Company retained
its patent portfolio and is looking to expand on its legacy celebrity worlds and
its collection of non-fungible tokens.



Basis of Presentation



The accompanying financial statements have been prepared in conformity with
accounting principles generally accepted in the United States of America ("US
GAAP"). The Company has incurred significant losses since its inception and has
had minimal revenues from operations. The Company will require substantial
additional funds for development and enforcement of its patent portfolio. There
can be no assurance that the Company will be able to obtain the substantial
additional capital resources to pursue its business plan or that any assumptions
relating to its business plan will prove to be accurate. The Company has not
been able to generate sufficient revenue or obtain sufficient financing which
has had a material adverse effect on the Company, including requiring the
Company to reduce operations. As the Company has focused its attention on
increasing its patent portfolio and enforcing it, the Company has been operating
at a reduced capacity, with only one employee and using consultants to perform
any additional work that may be required.



Use of Estimates



The preparation of financial statements in conformity with US GAAP requires
management to make estimates and assumptions that affect the reported amounts of
assets and liabilities and disclosures of contingent assets and liabilities at
the date of the financial statements and the reported amounts of revenues and
expenses during the reporting period. Actual results could differ from these
estimates.



Cash and Cash Equivalents


Cash and cash equivalents include highly liquid money market instruments, which have original maturities of three months or less at the time of purchase.





  23


  Contents






Revenue Recognition



Effective January 1, 2018, the Company adopted ASC 606. There was no impact in
adopting ASC 606 as the Company has no revenue at this time. In the second
quarter of 2011, the Company spun off its online businesses to MariMed Inc. The
Company's sources of revenue after the spinoff was expected to be from
sublicenses of the patented technology by Worlds Online and any revenue that may
be generated from enforcing its patents. The Company recognizes revenue by
applying the following steps: (1) identify the contract with a customer; (2)
identify the performance obligations in the contract; (3) determine the
transaction price; (4) allocate the transaction price to each performance
obligation in the contract; and (5) recognize revenue when each performance
obligation is satisfied.



Research and Development Costs

Research and development costs are charged to operations as incurred.





Property and Equipment



Property and equipment are stated at cost. Depreciation is provided on a
straight-line basis over the estimated useful lives of the assets ranging from
three to five years. When assets are retired or disposed of, the cost and
accumulated depreciation are removed from the accounts, and any resulting gains
or losses are included in income. Maintenance and repairs are charged to expense
in the period incurred.


Impairment of Long-Lived Assets





The Company evaluates the recoverability of its fixed assets and other assets in
accordance with section 360-10-15 of the FASB Accounting Standards Codification
for disclosures about Impairment or Disposal of Long-Lived Assets. Disclosure
requires recognition of impairment of long-lived assets in the event the net
book value of such assets exceeds its expected cash flows. If so, it is
considered to be impaired and is written down to fair value, which is determined
based on either discounted future cash flows or appraised values. The Company
adopted the statement on inception. No impairments of these types of assets were
recognized during 2019 and 2018.



Stock-Based Compensation



The Company accounts for stock-based compensation using the fair value method
following the guidance set forth in section 718-10 of the FASB Accounting
Standards Codification for disclosure about Stock-Based Compensation. This
section requires a public entity to measure the cost of employee services
received in exchange for an award of equity instruments based on the grant-date
fair value of the award (with limited exceptions). That cost will be recognized
over the period during which an employee is required to provide service in
exchange for the award (usually the vesting period). No compensation cost is
recognized for equity instruments for which employees do not render the
requisite service.



Income Taxes



The Company accounts for income taxes under Section 740-10-30 of the FASB
Accounting Standards Codification. Deferred income tax assets and liabilities
are determined based upon differences between the financial reporting and tax
basis of assets and liabilities and are measured using the enacted tax rates and
laws that will be in effect when the differences are expected to reverse.
Deferred tax assets are reduced by a valuation allowance to the extent
management concludes it is more likely than not that the assets will not be
realized. Deferred tax assets and liabilities are measured using enacted tax
rates expected to apply to taxable income in the years in which those temporary
differences are expected to be recovered or settled. The effect on deferred tax
assets and liabilities of a change in tax rates is recognized in the
consolidated statements of operations in the period that includes the enactment
date.



  24


  Contents






ASC 740 prescribes a comprehensive model for how companies should recognize,
measure, present, and disclose in their financial statements uncertain tax
positions taken or expected to be taken on a tax return. Under ASC 740, tax
positions must initially be recognized in the financial statements when it is
more likely than not the position will be sustained upon examination by the tax
authorities. Such tax positions must initially and subsequently be measured as
the largest amount of tax benefit that has a greater than 50% likelihood of
being realized upon ultimate settlement with the tax authority assuming full
knowledge of the position and relevant facts.



Notes Payable



The Company has $773,279 in short term notes outstanding at December 31, 2021
and December 31, 2020. These are old notes payable for which the statute of
limitations has passed and therefore the Company does not expect it will ever
have to repay those notes.



Comprehensive Income (Loss)



The Company reports comprehensive income and its components following guidance
set forth by section 220-10 of the FASB Accounting Standards Codification which
establishes standards for the reporting and display of comprehensive income and
its components in the financial statements. There were no items of comprehensive
income (loss) applicable to the Company during the period covered in the
financial statements.



Loss Per Share



Net loss per common share is computed pursuant to section 260-10-45 of the FASB
ASC. Basic net loss per share is computed by dividing net loss by the weighted
average number of shares of common stock outstanding during the period. As of
December 31, 2021 and December 31, 2020, there were 11,720,000 options and
4,380,000 warrants outstanding whose effect is anti-dilutive and not included in
diluted net loss per share for December 31, 2021 or for December 31, 2020. The
options and warrants may dilute future earnings per share.



Commitments and Contingencies



The Company follows subtopic 450-20 of the FASB Accounting Standards
Codification to report accounting for contingencies. Certain conditions may
exist as of the date the financial statements are issued, which may result in a
loss to the Company but which will only be resolved when one or more future
events occur or fail to occur. The Company assesses such contingent liabilities,
and such assessment inherently involves an exercise of judgment. In assessing
loss contingencies related to legal proceedings that are pending against the
Company or unasserted claims that may result in such proceedings, the Company
evaluates the perceived merits of any legal proceedings or unasserted claims as
well as the perceived merits of the amount of relief sought or expected to

be
sought therein.



If the assessment of a contingency indicates that it is probable that a material
loss has been incurred and the amount of the liability can be estimated, then
the estimated liability would be accrued in the Company's financial statements.
If the assessment indicates that a potentially material loss contingency is not
probable but is reasonably possible, or is probable but cannot be estimated,
then the nature of the contingent liability, and an estimate of the range of
possible losses, if determinable and material, would be disclosed.



Loss contingencies considered remote are generally not disclosed unless they
involve guarantees, in which case the guarantees would be disclosed. Management
does not believe, based upon information available at this time, that these
matters will have a material adverse effect on the Company's financial position,
results of operations or cash flows. However, there is no assurance that such
matters will not materially and adversely affect the Company's business,
financial position, and results of operations or cash flows.

  25


  Contents






During 2000 the Company was involved in a lawsuit relating to unpaid consulting
services. In April 2001 a judgment against the Company was rendered for
approximately $205,000. As of December 31, 2021, and December 31, 2020, the
Company recorded a reserve of $205,000 for this lawsuit, which is included in
accrued expenses in the accompanying balance sheets.



Risk and Uncertainties


The Company is subject to risks common to companies in the technology industries, including, but not limited to, litigation, development of new technological innovations and dependence on key personnel.

Off Balance Sheet Arrangements

The Company does not have any off-balance sheet arrangements.





Uncertain Tax Positions



The Company did not take any uncertain tax positions and had no adjustments to
unrecognized income tax liabilities or benefits pursuant to the provisions of
Section 740-10-25 for the year ended December 31, 2021.



Fair Value of Financial Instruments





The Company measures assets and liabilities at fair value based on an expected
exit price as defined by the authoritative guidance on fair value measurements,
which represents the amount that would be received on the sale of an asset or
paid to transfer a liability, as the case may be, in an orderly transaction
between market participants. As such, fair value may be based on assumptions
that market participants would use in pricing an asset or liability. The
authoritative guidance on fair value measurements establishes a consistent
framework for measuring fair value on either a recurring or nonrecurring basis
whereby inputs, used in valuation techniques, are assigned a hierarchical level.



The following are the hierarchical levels of inputs to measure fair value:

• Level 1 - Observable inputs that reflect quoted market prices in active


    markets for identical assets or liabilities.



• Level 2 - Inputs reflect quoted prices for identical assets or liabilities in

markets that are not active; quoted prices for similar assets or liabilities

in active markets; inputs other than quoted prices that are observable for

the assets or liabilities; or inputs that are derived principally from or

corroborated by observable market data by correlation or other means.

• Level 3 - Unobservable inputs reflecting the Company's assumptions

incorporated in valuation techniques used to determine fair value. These

assumptions are required to be consistent with market participant assumptions


    that are reasonably available.




The carrying amounts of the Company's financial assets and liabilities, such as
cash, other receivables, accounts payable & accrued expenses, due to related
party, notes payable and notes payables, approximate their fair values because
of the short maturity of these instruments. The Company's convertible notes
payable are measured at amortized cost.



Warrant and option expense was measured by using level 3 valuation.



  26


  Contents




Embedded Conversion Features



The Company evaluates embedded conversion features within convertible debt under
ASC 815 "Derivatives and Hedging" to determine whether the embedded conversion
feature(s) should be bifurcated from the host instrument and accounted for as a
derivative at fair value with changes in fair value recorded in earnings. If the
conversion feature does not require derivative treatment under ASC 815, the
instrument is evaluated under ASC 470-20 "Debt with Conversion and Other
Options" for consideration of any beneficial conversion feature.



Derivative Financial Instruments


The Company does not use derivative instruments to hedge exposures to cash flow,
market, or foreign currency risks. The Company evaluates all of its financial
instruments, including stock purchase warrants, to determine if such instruments
are derivatives or contain features that qualify as embedded derivatives. For
derivative financial instruments that are accounted for as liabilities, the
derivative instrument is initially recorded at its fair value and is then
re-valued at each reporting date, with changes in the fair value reported as
charges or credits to income.


For option-based simple derivative financial instruments, the Company uses the Black-Scholes option-pricing model to value the derivative instruments at inception and subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.

Recent Accounting Pronouncements

The Company has reviewed all recently issued, but not yet effective, accounting pronouncements, and does not believe the future adoption of any such pronouncements may be expected to cause a material impact on its financial condition or the results of its operations.





The Company accounts for stock-based compensation for employees and directors in
accordance with Accounting Standards Codification 718, Compensation ("ASC 718")
as issued by the FASB. ASC 718 requires all share-based payments to employees,
including grants of employee stock options, to be recognized in the statement of
operations based on their fair values. Under the provisions of ASC 718,
stock-based compensation costs are measured at the grant date, based on the fair
value of the award, and are recognized as an expense over the employee's
requisite service period (generally the vesting period of the equity grant). The
fair value of the Company's common stock options are estimated using the Black
Scholes option-pricing model with the following assumptions: expected
volatility, dividend rate, risk free interest rate and the expected life. The
Company expenses stock-based compensation by using the straight-line method. In
accordance with ASC 718 and, excess tax benefits realized from the exercise of
stock-based awards are classified as cash flows from operating activities. All
excess tax benefits and tax deficiencies (including tax benefits of dividends on
share-based payment awards) are recognized as income tax expense or benefit in
the condensed consolidated statements of operations. The Company accounts for
stock-based compensation awards issued to non-employees for services, as
prescribed by ASC 718-10, at either the fair value of the services rendered or
the instruments issued in exchange for such services, whichever is more readily
determinable, using the measurement date guidelines enumerated in Accounting
Standards Update ("ASU") 2018-07.



In February 2016, the FASB issued ASU 2016-02, "Leases" Topic 842, which amends
the guidance in former ASC Topic 840, Leases. The new standard increases
transparency and comparability most significantly by requiring the recognition
by lessees of right-of-use assets and lease liabilities on the balance sheet for
all leases longer than 12 months. Under the standard, disclosures are required
to meet the objective of enabling users of financial statements to assess the
amount, timing, and uncertainty of cash flows arising from leases. For lessees,
leases will be classified as finance or operating, with classification affecting
the pattern and classification of expense recognition in the income statement.
The Company adopted the new lease guidance effective January 1, 2019. The
Company is not a party to any leases and therefore is not showing any asset or
liability related to leases in the current period or prior periods.

  27


  Contents




NOTE 3 - NOTES PAYABLE


Notes payable at December 31, 2021 consist of the


                    following:
Unsecured note payable bearing 8% interest,
entire balance of principal and unpaid interest
due on demand                                           $                 

124,230



Unsecured note payable bearing 10% interest,
entire balance of principal and unpaid interest
due on demand                                           $                  649,049
Total notes                                             $                  773,279
                      2021                              $                  773,279
                      2022                              $                        0
                      2023                              $                        0
                      2024                              $                        0
                      2025                              $                        0
Total notes                                             $                  773,279



The Company imputed interest of $76,063 on the notes during the year ended December 31, 2021.





NOTE 4 - EQUITY



All common stock numbers and exercise prices in this Note are reflected on a
post reverse split (5 to 1) basis. As a result of the reverse split on February
9, 2018, the Company had to issue an additional 167 shares due to rounding.



During the year ended December 31, 2021, the Company issued 297,673 shares of
common stock as settlement of accounts payable to a related party. The value of
the shares at the date of issuance was $70,810 resulting in a loss of $8,685.



During the year ended December 31, 2021, the Company recorded an option expense
of $109,874 representing the amortization of the value of the options issued in
2020 that had not yet vested.



During the year ended December 31, 2020, the Company recorded an option expense
of $267,647 representing the amortization of the value of the options issued in
2020 and 2018 that had not yet vested.



During the year ended December 31, 2020, the Company issued 700,000 options.
300,000 options were issued to Chris Ryan, the Chief Financial Officer of the
Company, and 400,000 options were issued to Directors of the Company. The
Company recorded an option expense of $267,647 in 2020. $256,574 of this amount
relates to the 2018 grant to Mr. Kidrin, the CEO. $11,073 relates to the grant
in 2020 to Mr. Ryan, the CFO. The directors' options were granted on December
31, 2020 and no expense was recorded for these options. The option expense
represents the amortization of the value of the options issued in 2020 and 2018
that have not yet vested. The fair market value for Mr. Ryan's options was
calculated using the Black Scholes method assuming a risk free interest of .36%,
0% dividend yield, volatility of 204%, and an exercise price of $0.266 per share
with a market price of $0.266 per share at issuance date and an expected life of
5 years. The options vest one year from the date of grant.

  28


  Contents







                                     Stock Warrants and Options
      Stock warrants/options outstanding and exercisable on December 31, 2021 are as follows:
             Exercise Price
               per Share
             Exercise Price            Shares Under Option/warrant
               per Share               Shares Under Option/warrant         Remaining Life in Years
Outstanding
$                      0.325                            3,400,000                          0.08
$                       0.15                            5,220,000                          0.75
$                       0.15                              580,000                          1.00
$                       0.05                              200,000                          1.00
$                       0.30                              200,000                          1.00
$                       0.25                            5,000,000                          1.67
$                       0.24                              800,000                          1.67
$                       0.27                              300,000                          3.88
$                       0.30                              400,000                          4.00
Total                                                  16,100,000
Exercisable
$                      0.325                            3,400,000                          0.08
$                       0.15                            5,220,000                          0.75
$                       0.15                              580,000                          1.00
$                       0.05                              200,000                          1.00
$                       0.30                              200,000                          1.00
$                       0.25                            5,000,000                          1.67
$                       0.24                              800,000                          1.67
$                       0.27                              300,000                          3.88
$                       0.30                              400,000                          4.00
Total                                                  16,100,000






NOTE 5 - INCOME TAXES



At December 31, 2021, the Company had federal and state net operating loss carry
forwards of approximately $45,000,000 that expire in various years through

the
year 2041.


Due to net operating loss carry forwards and operating losses, there is no provision for current federal or state income taxes for the years ended December 31, 2021 and 2020.

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amount used for federal and state income tax purposes.





The Company's deferred tax asset at December 31, 2021 consists of net operating
loss carry forwards calculated using federal and state effective tax rates
equating to approximately $17,292,188 less a valuation allowance in the amount
of approximately $17,292,188. Because of the Company's lack of earnings history,
the deferred tax asset has been fully offset by a valuation allowance. The
valuation allowance increased by approximately $161,009 for the year ended
December 31, 2021 and increased by approximately $338,288 for the year ended
December 31, 2020.

  29


  Contents




The Company's total deferred tax asset as of December 31, 2021, and 2020 are as
follows:



Total Deferred Tax
                                         2021              2020
Net operating loss carry forwards   $  17,292,188     $  17,131,921
Valuation allowance                   (17,292,188 )     (17,131,179 )
Net deferred tax asset              $          -      $          -




The reconciliation of income taxes computed at the federal and state statutory
income tax rate to total income taxes for the years ended December 31, 2021

and
2020 is as follows:

Reconciliation of Income
                                                      2021       2020

Income tax computed at the federal statutory rate 21 % 21 % Income tax computed at the state statutory rate 5 % 5 % Valuation allowance

                                   (26 )%     (26 )%
Total deferred tax asset                               -          -




On December 22, 2017, the 2017 Tax Cuts and Jobs Act (the Tax Act) was enacted
into law and the new legislation contains several key tax provisions that
affected us, including a one-time mandatory transition tax on accumulated
foreign earnings and a reduction of the corporate income tax rate to 21%
effective January 1, 2018, among others. We are required to recognize the effect
of the tax law changes in the period of enactment, such as determining the
transition tax, remeasuring our U.S. deferred tax assets and liabilities as well
as reassessing the net realizability of our deferred tax asset and liabilities.
In December 2017, the SEC staff issued Staff Accounting Bulletin No. 118, Income
Tax Accounting Implications of the Tax Cuts and Jobs Act (SAB 118), which allows
us to record provisional amounts during a measurement period not to extend
beyond one year of the enactment date.



NOTE 6 - COMMITMENTS AND CONTINGENCIES


The Company is committed to an employment agreement with its President and CEO,
Thom Kidrin. The agreement, dated as of August 28, 2018, is for five years with
a one-year renewal option held by Mr. Kidrin.  The agreement provides for a base
salary of $200,000, which increases 10% on September 1 of each year; a monthly
car allowance of $500; an annual bonus equal to 2.5% of Pre-Tax Income (as
defined in the agreement); an additional bonus as follows: $75,000, if Pre-Tax
Income for the year is between 150% and 200% of the prior fiscal year's Pre-Tax
Income or (B) $100,000, if Pre-Tax Income for the year is between 201% and 250%
of the prior fiscal year's Pre-Tax Income or (C) $200,000, if Pre-Tax Income for
the year is 251% or greater than the prior fiscal year's Pre-Tax Income, but in
no event shall this additional bonus exceed five (5%) percent of Pre-Tax Income
for such year; payment of up to $10,000 in life insurance premiums; options to
purchase 5 million shares of Worlds Inc. common stock at an exercise price of
$0.25 per share, 2 million of which vested on August 28, 2018, 1.5 million shall
vest on August 28, 2019 and the remaining 1.5 million shall vest on August 28,
2020 ; a death benefit of at least $2 million dollars; and a payment equal to
2.99 times his base amount (as defined in the agreement) in the event of a
Change of Control (as defined in the agreement).  The agreement also provides
that Mr. Kidrin can be terminated for cause (as defined in the agreement) and
that he is subject to restrictive covenants for 12 months after termination.

  30


  Contents



NOTE 7 - RELATED PARTY TRANSACTIONS


The Company issued 297,673 shares of common stock to Chris Ryan, our CFO as
settlement of amounts previously recorded. The value of the shares on the date
of issuance was $70,810. The Company recorded a loss of $8,685 on the issuance
of the shares.


The Company recorded a gain on forgiveness of accounts payable related party due to the Company's CFO in the amount of $16,401.

The Company paid to the CFO, Chris Ryan, $9,000 over the year ended December 31, 2021, and $6,500 over the year ended December 31, 2020.

The balance in the accrued expense attributable to related parties is $33,899 and $82,214 at December 31, 2021 and December 31, 2020, respectively.

See note 11 for a discussion on the convertible note receivable from the related party.





NOTE 8 - PATENTS



Worlds Inc. currently has nine patents, 6,219,045- 7,181,690 - 7,493,558 - 7,945,856, - 8,082,501, - 8,145,998

- 8,161,383, - 8,407,592 and 8,640,028.

See Legal Proceedings section for more information on the patent infringement lawsuits.

NOTE 9 - SALE OF MARKETABLE SECURITIES

When Worlds Inc. spun off Worlds Online Inc. in January 2011, the Company retained 5,936,115 shares of common stock in Worlds Online Inc. (now named MariMed Inc.).





During the year ended December 31, 2021 the Company generated net cash of
$1,006,588 from the sale of 1,245,000 shares of MariMed Inc. common stock during
the year ended December 31, 2021 and 100,000 shares of MariMed Inc. common stock
at the end of December 2020 which was not transferred to the Company's bank
account until January of 2021. The average price per share was $0.79 per share.



As of December 31, 2021, the Company still owns approximately 1.7 million shares of MariMed Inc. common stock.

Those shares were retained on the books of the Company with a book value of $0. No shares were sold in the year ended December 31, 2020.





NOTE 10 - ACCRUED EXPENSES



Accrued expenses is comprised of $33,899 owed to related parties. $205,000 is
related to a judgment against the Company relating to unpaid consulting services
dating back to April of 2001. $1,305,009is related to old accruals for which the
statute of limitations has passed and therefore the Company does not expect it
will ever have to repay those amounts. The balance of $2,572 is related to
accruals for recurring operating expenses.

  31


  Contents





NOTE 11 - CONVERTIBLE NOTE RECEIVABLE - RELATED PARTY





The Company made an investment in the form of a convertible note in the amount
of $200,000 to Canadian American Standard Hemp (CASH). The convertible note has
a 7% annual interest rate and matures in 2 years. Interest and principle is
payable at maturity. The note can be converted at any time, either all or part
of the amount due can be converted into the borrower's equity. During the year
ended December 31, 2020, CASH merged with Real Brands, Inc. The note was amended
with a new maturity date of October 15, 2023. All other terms remained the same.
As consideration for the extension, the Company received one million warrants to
purchase Real Brands, Inc. common stock at $0.05 per share. The convertible note
and accrued interest of $31,461can be converted into 28,438,561 shares of Real
Brands common stock at a conversion price of $0.008139. If converted into common
stock, the Company would own approximately 1% of Real Brands Inc. Messrs.
Kidrin, Toboroff and Christos are Directors of Real Brands and Mr. Kidrin is the
CEO and Mr. Ryan is the CFO of Real Brands.



NOTE 12 - OTHER ASSETS

Other assets is comprised of an over payment to a law firm in the amount of $8,222.





NOTE 13 - SUBSEQUENT EVENTS



The Company signed an asset purchase agreement on January 18, 2022 with the CEO
of the Company Mr. Kidrin. The Company purchased from Mr. Kidrin assets
previously owned by MariMed Inc. (MRMD) and used in its 3D VR business, which
Mr. Kidrin received through a settlement of a lawsuit with MRMD. The Company
plans to use this IP to enter into the NFT market. In consideration for the IP,
Mr Kidrin received fifteen million options to purchase common stock in the
Company at the market price on January 18, 2022. The option expires three years
from the date of the agreement.



At the February 16, 2022 board meeting, the directors voted to reprice their
existing options at the current market price and extend the options exercise
date to 5 years from the date of the repricing. The board also approved the
annual option grants for the directors for the prior years' service that were
never issued and the current year.



On April 30, 2021, Judge Casper granted Activision's summary judgment motion,
entered an Order finding that all asserted patents were invalid as directed to
patent-ineligible subject matter, and terminated the Company's lawsuit, with
judgment for the Activision Entities.  The Company appealed this Order on May
28, 2021 to the U.S. Court of Appeals for the Federal Circuit, sitting in
Washington, D.C. Oral argument occurred on March 8, 2022.  On March 10, 2022,
the Federal Circuit issued an Order affirming the District Court's judgment.



  32


  Contents

© Edgar Online, source Glimpses